Avacta to present updated clinical data on AVA6000 at the European...
8 September 2024 Avacta Group plc (“Avacta” or “the Group” or “the Company”) Avacta to present updated clinical data on AVA6000 at the European Society for Medical Oncology (ESMO) Congress Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted cancer treatments...
SDAIA to Unveil Key AI Strategies and International Collaborations at Global...
RIYADH, Saudi Arabia, Sept. 9, 2024 /PRNewswire/ -- The Saudi Authority for Data and Artificial Intelligence (SDAIA) will hold a press conference on Sunday, September 8, at the King Abdulaziz International Conference Center. The press conference will highlight key aspects of the upcoming third edition of the Global AI...
Westwood Hart Announces Launch of New Retail E-commerce Platform
Malibu, CA, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Westwood Hart, a bespoke tailoring company with over five decades of experience, has announced the launch of its new retail e-commerce platform. This development marks a significant expansion in the company’s operations, enabling it to offer its...
Oncopeptides expands on WODA partnership with addition of Africa and Eurasia...
ZURICH and ZUG, Switzerland and STOCKHOLM, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Oncopeptides AB (STO: ONCO), a biotech company focused on difficult-to-treat cancers, and Veld Pharmaceuticals GmbH (“Veld”) and Slavpharma GmbH (“Slavpharma”) today announced a collaboration to commercialize Oncopeptides’ flagship drug Pepaxti (melphalan flufenamide) in Africa and...